文献速递免疫规划

灭活全病毒颗粒疫苗免疫原性强且IL-6诱导有限,适合流感疫苗

Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza.
PubMed 文献 · Vaccine · 2019-03-08

该研究由学术与产业合作,比较了灭活全流感病毒颗粒疫苗(WPV)与裂解疫苗(SV)的免疫效果。小鼠和猴子接种WPV后免疫应答优于SV;小鼠中A/California/07/2009(H1N1)WPV可抵抗致死剂量同源病毒,而SV接种鼠6天内死亡。WPV诱导多功能CD8+ T细胞及早期细胞因子,且五分之一剂量即可诱导强免疫并有限产生IL-6。

要点

  • WPV保留病毒原始结构和成分,免疫应答优于SV。
  • WPV使小鼠抵抗致死剂量同源病毒,SV接种鼠6天内死亡。
  • WPV诱导多功能CD8+ T细胞,对控制抗原漂移毒株重要。

核心结论

  • WPV诱导的固有和适应性免疫应答强于等效剂量的SV。
  • WPV在五分之一SV剂量下即可诱导强免疫且IL-6产生有限。
  • WPV具有平衡的免疫原性和安全性,可能成为季节性流感疫苗新标准。

研究设计与样本

  • 学术与产业合作研究,日本四家季节性流感疫苗生产商从同一批纯化流感病毒制备WPV和SV。
  • 在小鼠和猴子中比较WPV与对应SV的免疫应答。
  • 小鼠中评估A/California/07/2009(H1N1)WPV对致死剂量同源病毒攻击的保护。

主要发现

  • 接种WPV的小鼠和猴子免疫应答优于接种对应SV者。
  • 接种A/California/07/2009(H1N1)WPV的小鼠抵抗致死剂量同源病毒,而接种SV的小鼠6天内死于感染。
  • WPV接种小鼠诱导大量多功能CD8+ T细胞。
  • WPV接种小鼠血清早期检测到细胞因子和趋化因子,SV接种鼠未检测到。
  • WPV在五分之一SV剂量下诱导强免疫且IL-6产生有限。

关键数值与推荐

  • WPV剂量为SV的五分之一时仍能诱导强免疫且IL-6产生有限。
  • 接种SV的小鼠在致死剂量同源病毒攻击后6天内死亡。

临床怎么用

  • WPV可能提供优于SV的免疫原性,并保留病毒原始结构和成分。
  • WPV诱导的多功能CD8+ T细胞可能有助于控制抗原漂移流感病毒株。
  • WPV的低剂量免疫原性和有限IL-6诱导提示其具有平衡的免疫原性与安全性。

局限性

  • 研究主要在小鼠和猴子中进行,尚未在人体中验证。
  • WPV作为季节性流感疫苗的潜力需进一步临床试验评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In contrast to current ether- or detergent-disrupted "split" vaccines (SVs) for influenza, inactivated whole influenza virus particle vaccines (WPVs) retain the original virus structure and components and as such may confer similar immunity to natural infection. In a collaboration between academia and industry, the potential of WPV as a new seasonal influenza vaccine was investigated. Each of the four seasonal influenza vaccine manufacturers in Japan prepared WPVs and SVs from the same batches of purified influenza virus. Both mice and monkeys vaccinated with the WPVs exhibited superior immune responses to those vaccinated with the corresponding SVs. Vaccination with A/California/07/2009 (H1N1) WPV enabled mice to survive a lethal challenge dose of homologous virus whereas those vaccinated with SV succumbed to infection within 6 days. Furthermore, mice vaccinated with WPV induced substantial numbers of multifunctional CD8+ T cells, important for control of antigenically drifted influenza virus strains. In addition, cytokines and chemokines were detected at early time points in the sera of mice vaccinated with WPV but not in those animals vaccinated with SV. These results indicate that WPVs induce enhanced innate and adaptive immune responses compared to equivalent doses of SVs. Notably, WPV at one fifth of the dose of SV was able to induce potent immunity with limited production of IL-6, one of the pyrogenic cytokines. We thus propose that WPVs with balanced immunogenicity and safety may set a new global standard for seasonal influenza vaccines.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Sekiya T, Mifsud EJ, Ohno M, et al. Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza. Vaccine. 2019. PMID: 30857932. doi:10.1016/j.vaccine.2019.02.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。